Yabuuchi Hikaru, Tanaka Kenji, Maeda Miyako, Takemura Masaaki, Oka Masaki, Ohashi Rikiya, Tamai Ikumi
GenoMembrane, Inc., 75-1 Ono-cho, Tsurumi-ku, Yokohama, 230-0046, Japan.
Biopharm Drug Dispos. 2008 Nov;29(8):441-8. doi: 10.1002/bdd.629.
The dog bile salt export pump (BSEP; ABCB11) was cloned and expressed in a Sf9 insect cell system. The deduced amino acid sequence encodes a 1325-amino-acid protein, which shows 89.4% and 80.2% homology with human BSEP and rat Bsep, respectively. The transcript of the dog Bsep gene was detected at a high level in liver, but not other tissues, by quantitative RT-PCR. The BSEP-expressing membrane vesicles isolated from Sf9 cells exhibited saturable uptake of [(3)H]taurocholic acid with Michaelis constants (K(m)) of 33.7, 22.2 and 19.9 microM for the dog, rat and human transporters, respectively. The uptake of [(3)H]taurocholic acid by all three transporters was significantly inhibited by troglitazone, glibenclamide, and other several inhibitors, while pravastatin inhibited dog Bsep and human BSEP, but not rat Bsep at 100 microM. The IC(50) of troglitazone for dog Bsep, human BSEP, and rat Bsep were 32, 20, and 60 microM, and those of pravastatin were 441, 240 and >1,000 microM, respectively. In conclusion, while dog Bsep shows similar ATP-dependent bile acid transport characteristics to human BSEP and rat Bsep, there is a species difference in affinity for drugs such as pravastatin and troglitazone.
犬胆盐输出泵(BSEP;ABCB11)在Sf9昆虫细胞系统中被克隆并表达。推导的氨基酸序列编码一个1325个氨基酸的蛋白质,该蛋白质与人BSEP和大鼠Bsep的同源性分别为89.4%和80.2%。通过定量逆转录聚合酶链反应(RT-PCR)在肝脏中检测到犬Bsep基因的转录本水平很高,但在其他组织中未检测到。从Sf9细胞中分离出的表达BSEP的膜囊泡对[³H]牛磺胆酸表现出饱和摄取,犬、大鼠和人类转运体的米氏常数(K(m))分别为33.7、22.2和19.9微摩尔。曲格列酮、格列本脲和其他几种抑制剂显著抑制了所有三种转运体对[³H]牛磺胆酸的摄取,而普伐他汀在100微摩尔时抑制犬Bsep和人BSEP,但不抑制大鼠Bsep。曲格列酮对犬Bsep、人BSEP和大鼠Bsep的半数抑制浓度(IC(50))分别为32、20和60微摩尔,普伐他汀的IC(50)分别为441、240和>1000微摩尔。总之,虽然犬Bsep显示出与人类BSEP和大鼠Bsep相似的ATP依赖性胆汁酸转运特性,但对普伐他汀和曲格列酮等药物的亲和力存在种属差异。